Methods for cleaning pseudo-contaminated objects and objects, and methods for controlling the accuracy of cleaning operations

Abstract

To provide a test soil which can be attached directly to an object to be cleaned and is visually detectable.SOLUTION: Disclosed is a test soil comprising a plurality of molecules of labeled polypeptides, where the labeled polypeptide is a polypeptide to which a dye is added by a covalent bond, and the value of X calculated by the following formula is 100,000 or more: X=(number of dyes comprised in one molecule of labeled polypeptide)×(molar absorption coefficient of dye (M-1 cm-1)).SELECTED DRAWING: Figure 7

Description

[Technical Field]

[0001] The present invention relates to a method for cleaning an object, a method for controlling the accuracy of a cleaning operation, and a method for controlling the accuracy of a cleaning operation. [Background technology]

[0002] Medical instruments used in surgery or examinations, such as surgical scalpels, forceps, and endoscopes, are contaminated with body fluids and tiny tissue fragments. To make used medical instruments reusable, they must be thoroughly cleaned to remove these contaminants. It is also important to evaluate whether the cleaning process is properly performed. There are direct and indirect methods for evaluation. For example, a direct evaluation method involves applying sheep blood as a pseudo-contaminant (also called test soil) to the medical instrument, then cleaning the instrument and detecting any remaining proteins on the cleaned instrument. Protein detection is performed by visually staining the remaining proteins on the cleaned medical instrument using a protein-staining dye, such as Amido Black 10B.

[0003] A known indirect evaluation method involves washing an indicator with a layer of pseudo-contaminants together with a medical instrument to evaluate whether the cleaning has been performed properly. For example, Patent Document 1 describes an indicator that uses a mixture of gluten and Red No. 102 (also known as New Coccine) as pseudo-contaminants. The indicator is mainly used to evaluate cleaning by an automatic cleaning device called a washer-disinfector (WD). [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Japanese Patent Application Laid-Open No. 2009-056030 Summary of the Invention [Problem to be solved by the invention]

[0005] In the direct evaluation method, most of the pseudo-contaminants adhering to medical instruments are removed by cleaning, making it difficult to visually detect any remaining pseudo-contaminants. Therefore, a dye solution is applied or sprayed onto the cleaned medical instruments, but the medical instruments must be re-cleaned before they can be reused. In the indirect evaluation method, the purpose is to check the performance and operation of the WD using an indicator placed within the WD. Therefore, it is difficult to evaluate whether contaminants remain on the cleaned medical instruments themselves using the indicator.

[0006] To date, no pseudo-contaminant has been known that can be directly attached to an object to be cleaned and that can be visually detected. The present invention aims to provide such a pseudo-contaminant, a means for using it to clean objects, and a means for controlling the accuracy of the cleaning operation. [Means for solving the problem]

[0007] The present invention provides a pseudo-contaminant comprising multiple molecules of labeled polypeptide, wherein the labeled polypeptide is a polypeptide to which a dye is covalently attached, and the value of X calculated by the following formula is 100,000 or more. X = (number of dyes in one molecule of labeled polypeptide) × (molar extinction coefficient of dye (M -1 cm -1 ))

[0008] The present invention provides a method for cleaning an object, comprising the steps of attaching the above-described pseudo-contaminant to the object, and cleaning the object to which the pseudo-contaminant has been attached.

[0009] The present invention provides a method for controlling the accuracy of a cleaning operation, which includes the steps of attaching the above-mentioned pseudo-contaminants to an object, cleaning the object to which the pseudo-contaminants have been attached, evaluating the pseudo-contaminants remaining on the cleaned object based on a dye, and determining whether the cleaning operation was appropriate based on the evaluation results.

[0010] The present invention provides a method for controlling the accuracy of cleaning operations, which includes the steps of attaching the above-mentioned pseudo-contaminant to a first object, cleaning the first object to which the pseudo-contaminant has been attached and a second object to which a biological contaminant has been attached, evaluating the pseudo-contaminant remaining on the cleaned first object based on a dye, and determining whether the cleaning operation on the second object was appropriate based on the evaluation results. [Effects of the Invention]

[0011] According to the present invention, it is possible to visually evaluate whether or not the cleaning operation on the object was appropriate. [Brief explanation of the drawings]

[0012] [Figure 1] 1 is a schematic diagram showing an example of a pseudo-contaminant of the present embodiment housed in a container. FIG. [Figure 2] 1 is a graph showing the S / N ratio calculated from the absorbance (530 nm) value (S) of an erythrosin B (EB)-labeled albumin solution and the absorbance value (N) of phosphate-buffered saline (PBS) used as a blank. [Figure 3] 1 is a graph showing the correlation between the number of EBs contained in one molecule of EB-labeled albumin and the S / N ratio of absorbance. [Figure 4] This is a photograph of a stainless steel plate coated with EB-labeled albumin. [Figure 5] 1 is a graph showing the S / N ratio calculated from the absorbance (530 nm) value (S) of the EB-labeled casein solution and the absorbance value (N) of PBS. [Figure 6] This is a photograph of a stainless steel plate coated with EB-labeled casein. [Figure 7] Photographs of a stainless steel plate coated with EB-labeled albumin before and after cleaning. DETAILED DESCRIPTION OF THE INVENTION

[0013] The pseudo-contaminant of this embodiment is a composition containing multiple molecules of labeled polypeptide. The number of molecules of labeled polypeptide contained in the pseudo-contaminant of this embodiment is not particularly limited as long as it is two or more molecules. The pseudo-contaminant of this embodiment is an artificially produced composition that mimics a contaminant whose main component is polypeptide.

[0014] The labeled polypeptide contained in the pseudo-contaminant of this embodiment is a polypeptide to which a dye has been artificially added. In the labeled polypeptide, the dye and the polypeptide are covalently bonded. Therefore, it is believed that the dye will not be released from the labeled polypeptide by washing, which is typically performed on an object. In other words, the pseudo-contaminant of this embodiment is unlikely to be decolorized while attached to the object. Therefore, by detecting the dye of the labeled polypeptide contained in the pseudo-contaminant in the washed object, it is possible to evaluate whether the object has been sufficiently washed.

[0015] The polypeptide is not particularly limited in terms of its amino acid sequence, molecular weight, solubility in solvent, etc., and can be selected arbitrarily. Preferably, it is a polypeptide with a molecular weight of 20,000 or more. The polypeptide may be, for example, a polypeptide that is expected to adhere to the object to be cleaned. Such polypeptides are preferably proteins contained in mammalian body fluids or tissues. Examples of such proteins include albumin, casein, fibrin, globulin, hemoglobin, etc. Among these, albumin and casein are preferred. The type of albumin is not particularly limited, and examples include serum albumin, ovalbumin, lactalbumin, leucosin, legumelin, lysine, etc. The type of casein is not particularly limited, and examples include acid casein, sodium caseinate, α s -casein, β-casein, κ-casein, etc.

[0016] The dye is not particularly limited and may be a natural dye or a synthetic dye. Examples of dyes include dyes that exhibit visible colors and dyes that generate detectable signals. Dyes that exhibit visible colors are dyes that absorb and reflect visible light of a specific wavelength under white light. Examples include erythrosine (also known as erythrosine B), phloxine, rose bengal, tartrazine, amaranth, new coccine, allura red AC, and acid red. Examples of dyes that generate detectable signals include fluorescent dyes. A labeled polypeptide bearing a fluorescent dye can be visualized by irradiation with excitation light, such as black light (e.g., UV-A with a wavelength of approximately 315 nm to approximately 380 nm). Examples of fluorescent dyes include fluorescein-based dyes, cyanine-based dyes, rhodamine, acridine orange, and Alexa Fluor (registered trademark). Fluorescein-based dyes refer to fluorescein and its derivatives. Examples of fluorescein derivatives include fluorescein isothiocyanate, carboxyfluorescein, carboxyfluorescein diacetate, Oregon Green, and phosphafluorescein. Cyanine dyes refer to dyes having a structure in which nitrogen-containing heterocycles are attached to both ends of a polymethine skeleton. Examples of cyanine dyes include Cy (registered trademark) 3, Cy5, Cy7, TOTO (trademark)-1, TOTO-3, TO-PRO (trademark)-1, TO-PRO-3, and DiOC6(3).

[0017] The dye in the labeled polypeptide is preferably a red dye from the viewpoint of visibility. Here, red refers to a color that can be seen by an observer when observed under white light, as the dye absorbs visible light of wavelengths other than red and reflects red visible light (light with a wavelength of about 610 nm or more and about 780 nm or less). Examples of red dyes include erythrosine, phloxine, and rose bengal. Among these, erythrosine is particularly preferred.

[0018] The present inventors considered that the visibility of a labeled polypeptide correlates with the number of dyes contained in one molecule of the labeled polypeptide (hereinafter also referred to as the "number of labels") and the molar extinction coefficient, which is a value specific to each dye molecule. Therefore, the value of X calculated by the following formula (I) was defined as an index representing the intensity of labeling by the labeled polypeptide. Hereinafter, the value of X is also referred to as the "color tone index" or "CTI."

[0019] X = (number of dyes in one molecule of labeled polypeptide) × (molar extinction coefficient of dye (M -1 cm -1 )) ···(I)

[0020] The labeled polypeptide is characterized in that the value of X calculated by the above formula (I) is 100,000 or more. When the value of X is 100,000 or more, even a trace amount of the labeled polypeptide can be detected visually. The higher the value of X, the more intensely the labeled polypeptide will be colored. For example, the labeled polypeptide preferably has an X value of 350,000 or more, and more preferably an X value of 1,000,000 or more.

[0021] The number of labels is determined by mass spectrometry or by measuring the dye concentration and polypeptide concentration of the labeled polypeptide solution. Mass spectrometry is a MALDI-TOF MS method in which the labeled polypeptide is ionized by matrix-assisted laser desorption / ionization (MALDI) and then analyzed using a time-of-flight (TOF) mass spectrometer. The MALDI-TOF MS method itself is well known. If the labeled polypeptide can be analyzed by MALDI-TOF MS, the number of labels is determined by this method. Only if the labeled polypeptide cannot be analyzed by MALDI-TOF MS is the number of labels determined by measuring the dye concentration and polypeptide concentration of the labeled polypeptide solution. Whether or not the labeled polypeptide can be analyzed by MALDI-TOF MS depends on the type of polypeptide in the labeled polypeptide.

[0022] The number of labels determined by MALDI-TOF MS is calculated from the mass of the labeled polypeptide obtained by MALDI-TOF MS, the mass of the polypeptide in the labeled polypeptide, and the molecular weight of the dye using the following formula (II). The mass of the polypeptide may be measured by MALDI-TOF MS in the same manner as the labeled polypeptide. Alternatively, the mass value disclosed by the manufacturer or distributor of the polypeptide may be used. The molecular weight of the dye may be calculated from the structural formula of the dye, or the molecular weight disclosed by the manufacturer or distributor of the dye may be used.

[0023] (Number of Labels) = [(Mass of Labeled Polypeptide) - (Mass of Polypeptide)] / (Molecular Weight of Dye) (II)

[0024] The number of labels is determined by measuring the dye concentration and polypeptide concentration in a labeled polypeptide solution by calculating the number of labels from the following formula (III) using the dye and polypeptide concentrations in the labeled polypeptide solution determined by measurement. The "concentration" in formula (III) can be, for example, molar concentration, mass concentration, or volume percent concentration.

[0025] (Number of labels) = (dye concentration of labeled polypeptide solution) / (polypeptide concentration of labeled polypeptide solution) (III)

[0026] The dye concentration of a labeled polypeptide solution is measured as follows. First, a calibration curve is created based on the dye concentration of the dye solution and its absorbance. Specifically, solutions containing the dye itself at various concentrations are prepared, and the absorbance of each solution is measured at a wavelength at which the dye can be measured (e.g., the maximum absorption wavelength). The absorbance can be measured using a known spectrophotometer. A calibration curve is then created by plotting the absorbance corresponding to each dye concentration. Next, the absorbance of the labeled polypeptide solution is measured in the same manner as for the dye solution. The dye concentration of the labeled polypeptide solution is then determined from the absorbance value of the solution using the calibration curve.

[0027] The polypeptide concentration of a labeled polypeptide solution is measured as follows. First, a calibration curve is created based on the polypeptide concentration of the polypeptide solution and its absorbance. Specifically, solutions containing various concentrations of the polypeptide itself are prepared, and the polypeptide concentration of each solution is measured using the Pierce™ 660 nm Protein Assay Kit (Thermo Fisher Scientific). Specifically, the protein quantification reagent included in the kit is first mixed with the polypeptide solution, and the absorbance at 660 nm of the mixture is measured. A calibration curve is then created by plotting the absorbance corresponding to each polypeptide concentration. Next, the absorbance of the labeled polypeptide solution is measured in the same manner as for the polypeptide solution. The polypeptide concentration of the solution is then determined from the absorbance value of the labeled polypeptide solution using the calibration curve.

[0028] The molar extinction coefficient of the dye can be a value obtained by measurement. Alternatively, the molar extinction coefficient disclosed by the dye manufacturer or distributor can be used. The molar extinction coefficient of the dye (M -1 cm -1 ) can be calculated from the following formula (IV) using the measured values ​​of the absorbance of the dye solution, the optical path length (cm) of the spectrophotometer cell, and the dye concentration (M). Preferably, the molar absorption coefficients are calculated for multiple dye solutions with different dye concentrations, and their average value is used as the molar absorption coefficient of the dye. The dye concentration of the dye solution is a molar concentration, and is calculated as follows: First, a predetermined amount of dye is accurately weighed using a precision balance or electronic balance. Next, the weighed dye is dissolved in a solvent to prepare a solution of an accurately predetermined amount. The molar concentration is then calculated from the weighed weight of the dye, the volume of the solution, and the molecular weight of the dye. The solvent used to prepare the dye solution is used to measure the blank absorbance. The absorbance of the dye solution is measured as described above.

[0029]

number

[0030] A labeled polypeptide can be obtained by covalently linking a polypeptide to a dye. For example, it is preferable to covalently link the polypeptide and the dye using functional groups of the polypeptide and the dye. For example, a reaction using a condensing agent or a crosslinker is simple and preferable. Such reactions are known. The functional group is not particularly limited, but amino groups, carboxyl groups, and sulfhydryl groups are preferred because commercially available condensing agents and crosslinkers can be used.

[0031] The condensing agent is not particularly limited. For example, when covalently bonding a polypeptide and a dye by an amidation reaction, examples include 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM), 2-chloro-1,3-dimethylimidazolinium (DMC), 1H-benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate, diphenylphosphoryl azide, chlorotripyrrolidinophosphonium hexafluorophosphate, and N,N'-diisopropylcarbodiimide. Among these, DMT-MM, DMC, and 1H-benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate are preferred, with DMT-MM being particularly preferred. The amidation reaction using DMT-MM is as follows:

[0032] [ka]

[0033] The crosslinker is not particularly limited and can be appropriately selected depending on the functional groups of the polypeptide and dye. For example, a compound having an amino group as a functional group can be bonded to a compound having an N-hydroxysuccinimide (NHS) ester or an isothiocyano group (see the diagram below). For example, when bonding a polypeptide having an amino group to a dye having an amino group, a bifunctional reagent having NHS esters at both ends can be used as the crosslinker.

[0034] [ka]

[0035] A compound containing a carboxyl group as a functional group is first reacted with a compound containing a carbodiimide group (-N=C=N-) (see diagram below). In this example, it is reacted with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (Step 1). This is then reacted with NHS to form an unstable NHS ester (Step 2). This is then reacted with a compound containing an amino group, allowing it to be conjugated to a compound containing a carboxyl group (Step 3). For example, a dye (or polypeptide) containing a carboxyl group can be crosslinked with a polypeptide (or dye) containing an amino group in this manner. Alternatively, a bifunctional reagent containing amino groups at both ends can be used to crosslink a polypeptide containing a carboxyl group with a dye containing a carboxyl group.

[0036] [ka]

[0037] Compounds with sulfhydryl functional groups can be conjugated to compounds with maleimide or bromo(or iodo)acetamide groups (see diagram below). For example, when conjugating a polypeptide with sulfhydryl groups to a dye with sulfhydryl groups, a bifunctional reagent with maleimides at both ends can be used as a crosslinker. Furthermore, when conjugating a dye (or polypeptide) with sulfhydryl groups to a polypeptide (or dye) with amino groups, a heterobifunctional reagent with maleimide and NHS ester can be used as a crosslinker.

[0038] [ka]

[0039] In the labeled polypeptide, it is preferable that multiple molecules of the dye are bound to one molecule of the polypeptide. Therefore, when carrying out a reaction to bind the polypeptide and the dye, it is preferable to use a larger amount of dye than the amount of the polypeptide. For example, the polypeptide and the dye can be reacted at a molar ratio of 1:2 to 1:100.

[0040] If necessary, the pseudo-contaminant of this embodiment may contain components other than the labeled polypeptide. Examples of such components include lipids, carbohydrates, preservatives, antioxidants, pH adjusters, stabilizers, and the like. Examples of lipids include glycerides, cholesterol esters, higher fatty acids, phospholipids, glycolipids, and the like. Examples of carbohydrates include glucose, glycogen, dextran, starch, and the like. Examples of preservatives include sodium azide and thimerosal. Examples of antioxidants include ascorbic acid and butylhydroxyanisole. Examples of pH adjusters include phosphoric acid, citric acid, succinic acid, and salts thereof. Examples of stabilizers include polyethylene glycol and polyvinylpyrrolidone.

[0041] The simulated contaminant of this embodiment may be contained in a container, which may then be packed in a box and provided to a user. The simulated contaminant may be in a solid state such as a powder, or in a liquid state such as a solution or suspension. The box may also contain an accompanying document that describes how to use and store the simulated contaminant of this embodiment. Figure 1 shows an example of the simulated contaminant of this embodiment. Referring to Figure 1, 10 denotes a container containing the simulated contaminant of this embodiment, 11 denotes a packaging box, and 12 denotes the accompanying document.

[0042] Another embodiment of the present invention relates to a method for cleaning an object using a simulated contaminant. Hereinafter, this method will also be referred to as the "cleaning method of this embodiment." In this cleaning method, first, the simulated contaminant of this embodiment is attached to the object. The object is not particularly limited as long as it is an instrument that can be reused by cleaning. Examples of such instruments include medical instruments, tableware, and cooking utensils. Among these, medical instruments are preferred, and instruments that come into contact with a patient's body or biological samples are particularly preferred. Examples of medical instruments include surgical knives, forceps, scissors, tubes, catheters, syringes, and endoscopes. Medical instruments are not limited to instruments directly used by doctors, etc., but also include, for example, medical instruments used in surgical support robots. Furthermore, the medical instrument may be an electronic device as long as it is washable. The object may be one or more.

[0043] In the cleaning method of this embodiment, the pseudo-contaminant is preferably used in the form of a solution or suspension. The concentration of the labeled polypeptide in the solution or suspension is not particularly limited. For example, the pseudo-contaminant solution or suspension of this embodiment may contain, expressed in terms of polypeptide concentration, for example, 0.1 μg / mL or more, 1 μg / mL or more, 10 μg / mL or more, 0.1 mg / mL or more, or 0.5 mg / mL or more of the labeled polypeptide. The pseudo-contaminant solution or suspension of this embodiment may contain, expressed in terms of polypeptide concentration, for example, 300 mg / mL or less, 100 mg / mL or less, 50 mg / mL or less, 15 mg / mL or less, or 5 mg / mL or less of the labeled polypeptide. The medium is not particularly limited as long as it can dissolve or disperse the labeled polypeptide, but is preferably an aqueous medium. Examples of aqueous media include water, saline, and buffer solutions. The buffer solution preferably has a buffering effect at a pH of 6 to 8, and examples include phosphate-buffered saline (PBS), Tris-HCl, and Good's buffer (e.g., HEPES and MOPS).

[0044] The attachment of the pseudo-contaminant to the object can be carried out, for example, by applying, spraying, dripping, or printing a solution or suspension of the pseudo-contaminant onto the object, or by immersing the object in the solution or suspension of the pseudo-contaminant. After the solution or suspension of the pseudo-contaminant has been attached, it is preferable to dry the object to which the solution or suspension has been attached by air drying or hot air. The location on the object to which the pseudo-contaminant is attached is not particularly limited. Such a location can be selected from locations to which actual contaminants can be attached, such as the outer surface, inner surface, or cavity of the object. The location on one object to which the pseudo-contaminant is attached may be one location, or two or more locations. The amount of pseudo-contaminant to be attached is not particularly limited, but for example, the amount of pseudo-contaminant to be attached is preferably 100% or more, expressed in terms of polypeptide concentration, per 1 cm of the object. 2 The simulated contaminants of this embodiment are attached to the object at a rate of, for example, 2 μg or more, 10 μg or more, 50 μg or more, 200 μg or more, 500 μg or more, 1000 μg or more, 1500 μg or more, or 1800 μg or more per cm. In the field of medical instrument cleaning, the amount of protein remaining after cleaning is 2 μg / cm. 2 It is required to be less than.

[0045] Next, in the cleaning method of this embodiment, the object with the pseudo-contaminants attached is cleaned. The cleaning method is not particularly limited and can be determined appropriately depending on the object. Examples include manual cleaning, ultrasonic cleaning, and cleaning using a washer-disinfector (WD). Manual cleaning includes immersion in water or a detergent solution, brushing, and rinsing. Ultrasonic cleaning involves irradiating the object with ultrasonic waves while immersed in water or a detergent solution. A commercially available ultrasonic cleaning device is preferably used. WD cleaning involves spraying water or a detergent solution onto the object placed in a commercially available WD. The water temperature is not particularly limited, but is typically between 10°C and 100°C, preferably between 40°C and 90°C. The detergent is not particularly limited and can be appropriately selected from known detergents depending on the object and cleaning method. Examples include alkaline detergents and neutral detergents. The detergent may contain enzymes such as protease, lipase, and amylase. The concentration of the cleaning solution is not particularly limited and can be determined appropriately depending on the type of cleaning agent and the cleaning method. For example, when cleaning an object by immersing it in a cleaning solution, the cleaning agent concentration in the solution is usually 0.5% by weight or more and 1% by weight or less.

[0046] In the cleaning method of this embodiment, the amount of pseudo-contaminants remaining on the cleaned object can be an indicator of whether the cleaning operation was appropriate. For example, if no pseudo-contaminants of this embodiment remain on the cleaned object, it suggests that the cleaning operation on the object was appropriate. On the other hand, if pseudo-contaminants of this embodiment remain on the cleaned object, it suggests that the cleaning operation on the object was inappropriate. The degree of inappropriateness of the cleaning operation can be evaluated based on the amount of pseudo-contaminants remaining on the object.

[0047] Whether or not the pseudo-contaminant of this embodiment remains on a washed object can be confirmed visually. For example, when a pseudo-contaminant containing a labeled polypeptide bound to a red dye is used, if the washing procedure is inappropriate, red deposits on the object can be confirmed by visual observation under white light. When the washing procedure is appropriate, no red deposits on the object can be confirmed by visual observation under white light. Furthermore, when a pseudo-contaminant containing a labeled polypeptide bound to a fluorescent dye is used, if the washing procedure is inappropriate, fluorescent deposits on the object can be confirmed by visual observation under irradiation with excitation light. When the washing procedure is appropriate, no fluorescent deposits on the object can be confirmed by visual observation under irradiation with excitation light.

[0048] A further embodiment of the present invention relates to a method for controlling the quality of a cleaning operation using the simulated contaminant of this embodiment. Hereinafter, this method will also be referred to as the "quality control method of this embodiment." In the quality control method of this embodiment, first, the simulated contaminant of this embodiment is attached to an object. Then, the object to which the simulated contaminant is attached is cleaned. Details of the attachment of the simulated contaminant and the cleaning of the object are the same as those described for the cleaning method of this embodiment.

[0049] In the quality control method of this embodiment, pseudo-contaminants remaining in a washed object are evaluated based on the dye of the labeled polypeptide contained in the pseudo-contaminant. For example, whether or not pseudo-contaminants remain in a washed object can be evaluated based on whether or not the dye can be visually confirmed. Specifically, if the dye of the labeled polypeptide is observed when the washed object is visually observed, it can be determined that pseudo-contaminants remain in the object. In this case, it can be determined that the washing operation for the object was inappropriate. On the other hand, if the dye of the labeled polypeptide is not observed when the washed object is visually observed, it can be determined that the pseudo-contaminants have been removed from the object. In this case, it can be determined that the washing operation for the object was appropriate.

[0050] For example, when a pseudo-contaminant containing a labeled polypeptide bound to a red dye is used, if red deposits are observed when the cleaned object is visually observed under white light, it can be evaluated that the pseudo-contaminant remains. When a cleaned object is visually observed under white light, it can be evaluated that the pseudo-contaminant has been removed. Furthermore, when a pseudo-contaminant containing a labeled polypeptide bound to a fluorescent dye is used, if fluorescent deposits are observed when the cleaned object is irradiated with excitation light and visually observed, it can be evaluated that the pseudo-contaminant remains. When a cleaned object is irradiated with excitation light and visually observed, it can be evaluated that the pseudo-contaminant has been removed.

[0051] In the quality control method of this embodiment, an object having a pseudo-contaminant attached thereto is cleaned, and another object having a biological contaminant attached thereto may also be cleaned in the same manner. Thus, a further embodiment of the present invention relates to a quality control method for a cleaning operation by cleaning a first object having a pseudo-contaminant attached thereto and a second object having a biological contaminant attached thereto. Hereinafter, this method is also referred to as a "quality control method of a further embodiment."

[0052] In a further embodiment of the quality control method, first, a pseudo-contaminant is attached to a first object. The first object is an object to which the pseudo-contaminant will be attached. The type of object itself is the same as the object in the cleaning method of this embodiment. The first object is preferably a medical instrument, more preferably an unused or cleaned medical instrument. Details of the attachment of the pseudo-contaminant to the first object are the same as those described for the cleaning method of this embodiment.

[0053] The second object is a separate object from the first object, and is an object to which biological contaminants have adhered due to use. The type of object itself is the same as the object in the cleaning method of this embodiment. A preferred second object is a medical instrument that has been used and not yet cleaned. The second object may be the same type of instrument as the first object, or a different type of instrument from the first object.

[0054] The biological contaminant is not particularly limited as long as it is a substance that adheres to a second object as a result of the second object being used in a living organism. Examples of such contaminants include body fluids, skin fragments, fat fragments, cells, tissue fragments, bone fragments, sputum, vomit, urine, and feces. Examples of body fluids include blood, lymph, cerebrospinal fluid, saliva, digestive fluid, ascites, nasal mucus, and pus. The biological contaminant that adheres to the second object may be in a wet or dry state. The biological contaminant is not limited to one type, and two or more types of contaminants, or a mixture thereof, may adhere.

[0055] In a further embodiment of the quality control method, a first object having pseudo-contaminants attached thereto and a second object having biological contaminants attached thereto are cleaned. Details of the cleaning means are the same as those described for the cleaning method of this embodiment. In the cleaning step of the quality control method of this further embodiment, the first object and the second object may be cleaned together. For example, when cleaning by immersion in a detergent solution, the first object and the second object can be cleaned together by placing them in a single cleaning tank containing the detergent solution. Furthermore, when cleaning by ultrasonic cleaning or WD, the first object and the second object can be cleaned together by placing them in a single ultrasonic cleaning device or WD.

[0056] Alternatively, in the cleaning step of a further embodiment of the quality control method, the first object and the second object may be cleaned separately, substantially simultaneously, or sequentially, as long as the cleaning means and conditions are the same. For example, in the case of manual cleaning, the first object may be brushed and rinsed, and then the second object may be brushed and rinsed in the same manner. When manual cleaning is performed by multiple people, one person may brush and rinse the first object, and another person may brush and rinse the second object in the same manner. Furthermore, when cleaning by ultrasonic cleaning or WD, the first object is first cleaned by ultrasonic cleaning or WD. Then, the second object is cleaned by ultrasonic cleaning or WD using the same device settings and the same location as for cleaning the first object. Two ultrasonic cleaning devices or WDs may be used, with the same device settings, to clean the first object and the second object separately but substantially simultaneously.

[0057] In a further embodiment of the quality control method, residual pseudo-contaminants on a cleaned first object are evaluated based on a dye. In this quality control method, the first object with the pseudo-contaminants attached and the second object with the biological contaminants attached are cleaned in the same way, so the residual pseudo-contaminants on the cleaned first object serve as an indicator of the accuracy of the cleaning operation for the second object. Details of the dye-based evaluation of residual pseudo-contaminants are the same as those described for the quality control method of this embodiment.

[0058] For example, if the dye of the labeled polypeptide is observed upon visual observation of a washed first object, it can be determined that a pseudo-contaminant remains on the first object. In this case, it can be determined that the washing procedure for the first object was inappropriate, and therefore it can be determined that the washing procedure for the similarly washed second object was also inappropriate. On the other hand, if the dye of the labeled polypeptide is not observed upon visual observation of the washed first object, it can be determined that the pseudo-contaminant has been removed from the first object. In this case, it can be determined that the washing procedure for the first object was appropriate, and therefore it can be determined that the washing procedure for the similarly washed second object was also appropriate.

[0059] The amount of pseudo-contaminants remaining on the washed first object may be quantified based on the dye. For example, all pseudo-contaminants remaining on the washed first object are removed and dissolved or suspended in a predetermined amount of aqueous solvent. The dye in the resulting solution or suspension is measured, for example, using a spectrophotometer. The dye concentration in the solution or suspension is then calculated based on the absorbance measurement. The dye concentration value can be used as the remaining amount of pseudo-contaminants.

[0060] In a further embodiment of the quality control method, the appropriateness of the cleaning operation for the second object may be evaluated based on the amount of pseudo-contaminants remaining on the cleaned first object. For example, if the amount of pseudo-contaminants remaining on the first object is evaluated to be equal to or greater than a predetermined value, it can be determined that the cleaning operation for the second object was inappropriate. Alternatively, if the amount of pseudo-contaminants remaining on the first object is evaluated to be less than a predetermined value or no pseudo-contaminants remain, it can be determined that the cleaning operation for the second object was appropriate. The predetermined value is not particularly limited and may be determined appropriately depending on the types of the first and second objects.

[0061] If the cleaning operation for the second object is determined to be appropriate, the second object after cleaning can be reused. If the cleaning operation for the second object is determined to be inappropriate, it is preferable not to reuse the second object after cleaning. It is also preferable to improve the cleaning operation and clean the second object again.

[0062] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples. [Example]

[0063] Example 1: Preparation and evaluation of simulated contaminants Erythrosin B (EB)-labeled bovine serum albumin (BSA) was prepared by conjugating EB with BSA using various condensation agents. To determine which condensation agent was best, the absorbance (530 nm) of the EB-labeled BSA and the number of EBs per molecule were measured. The prepared EB-labeled BSA was applied to an object to evaluate its applicability as a pseudo-contaminant.

[0064] 1. Preparation of EB-labeled BSA EB (Tokyo Chemical Industry Co., Ltd.) was dissolved in PBS to obtain an EB solution. Condensing agents 1 to 9 listed in Table 1 were each dissolved in dimethyl sulfoxide (DMSO) to obtain a solution of each condensing agent. BSA was dissolved in PBS to obtain a BSA solution. The EB solution and the condensing agent solution were mixed in a molar ratio of 1:1.5 and allowed to stand at room temperature for 10 minutes. Then, a solution containing EB and the condensing agent was mixed with a BSA solution in a molar ratio of 100:1 and allowed to stand at room temperature for 1 hour. This resulted in a solution containing EB-labeled BSA in which EB and BSA were covalently bound. For comparison, the EB solution and the BSA solution were mixed without the condensing agent solution to obtain a solution containing a physically adsorbed EB-BSA complex (hereinafter also referred to as a control). Each of the obtained solutions was purified by passing through a desalting column. A portion of each solution was taken, and the BSA concentration of each solution was determined by measuring the absorbance at 660 nm using a Pierce™ 660 nm Protein Assay Kit (Thermo Fisher Scientific). Condensing agents 1, 4, and 7 were purchased from Tokyo Chemical Industry Co., Ltd., and condensing agents 2, 3, 5, 6, 8, and 9 were purchased from Fujifilm Wako Pure Chemical Corporation.

[0065] [Table 1]

[0066] 2. Evaluation of the number of EBs in EB-labeled BSA (2.1) Measurement of absorbance (530 nm) of EB-labeled BSA The BSA concentration of each EB-labeled BSA solution was adjusted to 1.6 μg / mL with PBS. A portion of each solution was taken and its absorbance at 530 nm was measured using a spectrophotometer. The absorbance of the EB-labeled BSA solution prepared using condensation agents 1–9 was taken as the signal value (S), and the absorbance of the blank PBS was taken as the noise value (N), and the S / N ratio of each solution was calculated. The results are shown in Figure 2.

[0067] (2.2) Determination of the number of EBs in EB-labeled BSA by MALDI-TOF MS A solution containing 30% acetonitrile and 0.10% trifluoroacetic acid (hereafter referred to as TA30 solution) was prepared by mixing acetonitrile and trifluoroacetic acid with ultrapure water. Sinapic acid (1.0 mg) was added to 0.10 mL of the TA30 solution and sonicated for 10 minutes. The resulting solution was centrifuged, and the collected supernatant was used as the matrix. 10 μL of the EB-labeled BSA solution (2.1) was diluted 2-fold with 0.20% trifluoroacetic acid in aqueous solution. A ZipTip U-C18 (Merck Millipore) was attached to a micropipette, and the resin tip was washed with 10 μL of TA30 solution. The EB-labeled BSA solution was then adsorbed onto the washed resin. The matrix (3.0 μL) was aspirated, and the EB-labeled BSA was eluted onto a MALDI plate (Bruker). After drying the samples on the plate, the mass per molecule of each EB-labeled BSA was measured using an Ultraflex MALDI-TOF MS (Bruker). For comparison, a control solution was also measured in the same manner. From the mass of the EB-labeled BSA obtained, the mass of BSA (66,463 Da), and the molecular weight of EB (879.86), the number of EBs per molecule of EB-labeled polypeptide (hereinafter also referred to as the EB labeling number) was calculated using the following formula. The results are shown in Table 2. In Table 2, the EB-labeled BSA is indicated by the condensing agent used in its preparation. Note that in the control, EB and BSA were not covalently bonded, so EB and BSA dissociated during MALDI-TOF MS measurement, resulting in a 0 EB labeling number.

[0068] (Number of EB labels) = [(mass of EB-labeled BSA obtained) - (mass of BSA)] / (molecular weight of EB)

[0069] [Table 2]

[0070] (2.3) Results As shown in Figure 2, the S / N ratios of EB-labeled BSA prepared using condensation agents 1 and 2 were significantly high. Furthermore, relatively good S / N ratios were observed for EB-labeled BSA prepared using condensation agents 3 to 5. Because 530 nm is the peak absorbance wavelength for EB aqueous solutions, a high S / N ratio of absorbance at 530 nm suggests a high number of EBs bound to BSA. Table 2 indicates that at least one EB molecule bound to each BSA molecule in EB-labeled BSA prepared using condensation agents 1 to 6. The number of EBs labeled was particularly high when condensation agents 1 to 3 were used. The correlation between the number of EBs labeled and the S / N ratio of absorbance at 530 nm was examined. The results are shown in Figure 3. As can be seen from Figure 3, the higher the number of EBs labeled, the higher the S / N ratio of absorbance.

[0071] 3. Use of EB-labeled BSA as a pseudocontaminant The surface of a stainless steel plate (hereinafter referred to as the stainless steel plate) (approximately 1 cm 2 ) and EB-labeled BSA solutions prepared using condensation agents 1 to 6 and a control solution were added at 2 μg / cm 2 (based on BSA concentration) and allowed to dry. In the field of medical instrument cleaning, the amount of residual protein is 2 μg / cm 2Since the EB-labeled BSA coating was required to be less than 100%, the stainless steel plates coated with EB-labeled BSA simulated medical instruments after cleaning. Photographs of the stainless steel plates coated with each EB-labeled BSA are shown in Figure 4. In Figure 4, the EB-labeled BSA is indicated by the condensing agent used in its preparation. Referring to Figure 4, the presence of EB-labeled BSA prepared using condensing agents 1 to 6 could be confirmed visually. In particular, the EB-labeled BSA prepared using condensing agents 1 to 3 clearly showed red deposits derived from EB. On the other hand, it was difficult to confirm the presence of the control by visual inspection.

[0072] 4. Determination of indicators characterizing suspected contaminants We investigated the performance of EB-labeled BSA as a pseudo-contaminant using an index based on the EB-labeled BSA itself, rather than the type of condensation agent used in its preparation. We hypothesized that the visibility of pseudo-contaminants correlates with the molar extinction coefficient of EB and the number of EB labels. Therefore, we determined a color tone index based on the molar extinction coefficient of EB and the number of EB labels.

[0073] (4.1) Determination of the molar extinction coefficient of EB 660.0 mg of EB (molecular weight 879.86) was weighed out accurately and dissolved in ultrapure water to make exactly 50 mL. The resulting EB aqueous solution (15 mM) was diluted with ultrapure water to prepare EB aqueous solutions of 37.5 μM, 18.75 μM, and 9.375 μM. The absorbance at 530 nm of each EB aqueous solution and ultrapure water (EB concentration 0 μM) as a blank was measured using a spectrophotometer. The optical path length of the spectrophotometer cell was 1 cm. The molar extinction coefficient (M -1 cm -1 The results are shown in Table 3.

[0074] (Molar extinction coefficient of EB) = [(absorbance of EB aqueous solution) - (absorbance of blank)] / [(EB concentration) × 10 -6 ×1]

[0075] [Table 3]

[0076] The average molar absorption coefficient of the EB aqueous solutions of 37.5 μM, 18.75 μM, and 9.375 μM was calculated. The average value was 76579. Hereinafter, this average value was used as the molar absorption coefficient of EB.

[0077] (4.2) Calculation of color tone index (CTI) of EB-labeled BSA The CTI of EB-labeled BSA prepared using condensing agents 1 to 6 was calculated using the number of EB labels determined in (2.2) above and the molar extinction coefficient of EB determined in (4.1) above, according to the following formula. The data obtained so far for each EB-labeled BSA, including the CTI, are shown in Table 4. In the table, in the visual determination section, "-" indicates that it was difficult to visually confirm the presence of EB-labeled BSA on the stainless steel plate, "+" indicates that the presence of EB-labeled BSA on the stainless steel plate was confirmed visually, and "++" indicates that the presence of EB-labeled BSA on the stainless steel plate was confirmed visually in a shorter time than in the case of "+" or instantly.

[0078] (CTI) = (number of EBs per molecule of EB-labeled polypeptide) × (molar extinction coefficient of EB)

[0079] [Table 4]

[0080] Table 4 shows that EB-labeled BSA with a CTI value of 100,000 or more can be used as a pseudo-contaminant. In particular, EB-labeled BSA with a CTI value of 1,000,000 or more was shown to be a pseudo-contaminant with excellent visibility.

[0081] Example 2: Preparation and evaluation of simulated contaminants (2) EB-labeled casein was prepared by covalently binding EB to casein using DMT-MM. The absorbance (530 nm) and labeling number of EB-labeled casein were measured. The prepared EB-labeled casein was applied to an object to evaluate its applicability as a pseudo-contaminant.

[0082] 1. Preparation of EB-labeled Casein EB solution and DMT-MM solution (10 mM) were prepared in the same manner as in Example 1. Casein (Fujifilm Wako Pure Chemical Industries, Ltd.) was dissolved in PBS to obtain a casein solution. The EB solution and DMT-MM solution were mixed in the molar ratios (conditions 1 to 6) shown in Table 5 and allowed to stand at room temperature for 10 minutes. A solution containing EB and a condensing agent was then mixed with the casein solution in a molar ratio of 100:1 and allowed to stand at room temperature for 1 hour. This resulted in a solution containing EB-labeled casein in which EB and casein were covalently bonded. Each of the resulting solutions was purified by passing through a desalting column. A portion of each solution was taken and the absorbance at 660 nm was measured using a Pierce™ 660 nm Protein Assay Kit (Thermo Fisher Scientific) as a protein quantification reagent to determine the casein concentration of each solution. A calibration curve used to determine the concentration was prepared based on the dry weight of casein.

[0083] [Table 5]

[0084] 2. Evaluation of the number of EBs in EB-labeled casein (2.1) Measurement of absorbance (530 nm) of EB-labeled casein The absorbance at 530 nm of the EB-labeled casein solution (casein concentration 1.6 μg / mL) was measured using a spectrophotometer. The absorbance of the solutions containing EB-labeled casein prepared under conditions 1 to 6 was taken as the signal value (S), and the absorbance of the blank PBS was taken as the noise value (N), and the S / N ratio of each solution was calculated. The results are shown in Figure 5.

[0085] (2.2) Determination of the number of EBs per molecule of EB-labeled casein It was difficult to measure EB-labeled casein using MALDI-TOF MS. Therefore, the EB labeling number was calculated from the EB concentration and casein concentration of the EB-labeled casein solutions prepared under conditions 1 to 6. Specifically, the procedure was as follows. First, the above EB solution was diluted with PBS to prepare a dilution series of EB solutions containing EB at various concentrations. The absorbance (530 nm) of the dilution series was measured, and the absorbance corresponding to each EB concentration was plotted to create a calibration curve. Using this calibration curve, the EB concentrations of the EB-labeled casein solutions prepared under conditions 1 to 6 were determined from the signal value (S) obtained in (2.1) above. The EB concentration value of each solution was divided by the casein concentration value (1.6 μg / mL). The obtained value was used as the EB labeling number of the EB-labeled casein. The CTI of the EB-labeled casein was calculated using the EB labeling number and the molar extinction coefficient of EB according to the formula in Example 1. The results are shown in Table 6. Table 6 shows the EB-labeled casein and the conditions used for its preparation.

[0086] [Table 6]

[0087] 3. Use of EB-labeled casein as a pseudocontaminant The surface of the stainless steel plate (approx. 1 cm 2 ) and EB-labeled casein solutions prepared under conditions 1 to 6 were added at 2 μg / cm 2 The EB-labeled caseins were applied in an amount of 0.01g (based on the casein concentration) and then dried. Photographs of stainless steel plates coated with each type of EB-labeled casein are shown in Figure 6. In the figure, the EB-labeled caseins are indicated by the conditions used for their preparation. Referring to Figure 6, the EB-labeled caseins prepared under conditions 1 and 2 clearly showed red EB-derived deposits by visual inspection. On the other hand, the EB-labeled caseins prepared under conditions 3 to 6 showed their presence by visual inspection, but no EB-derived red color was observed. For comparison, data on the EB-labeled caseins prepared under conditions 1 to 4 are shown in Table 7. In the table, a "-" in the visual inspection column indicates that it was difficult to visually confirm the presence of the EB-labeled casein on the stainless steel plate, and a "+" indicates that the presence of the EB-labeled casein on the stainless steel plate was visually confirmed.

[0088] [Table 7]

[0089] Table 7 shows that EB-labeled casein with a CTI value of 350,000 or more is a pseudo-contaminant with excellent visibility.

[0090] Example 3: Cleaning an object with suspected contamination The stainless steel plate to which EB-labeled BSA was attached as a pseudo-contaminant was washed with ultrapure water or a detergent solution, and it was evaluated whether or not the pseudo-contaminant remained.

[0091] 1. Attachment of pseudo-contaminants to the object and cleaning EB-labeled BSA was prepared in the same manner as in Example 1, using DMT-MM as the condensation agent. 500 μL of a solution containing EB-labeled BSA (BSA concentration: 5 mg / mL) was applied to each of two stainless steel plates and air-dried. To simulate insufficient cleaning, one of the stainless steel plates was immersed in ultrapure water (25°C) for 10 minutes, and then the surface was washed with running water for 1 minute. To simulate thorough cleaning, the other stainless steel plate was immersed in an alkaline detergent (1 wt% sodium dodecyl sulfate (Fujifilm Wako Pure Chemical Industries, Ltd.) and 0.1 M sodium hydroxide (Kishida Chemical Co., Ltd.)) (25°C) for 10 minutes, and then the surface was washed with running water for 1 minute. After cleaning, each stainless steel plate was visually inspected for the presence or absence of EB-labeled BSA remaining.

[0092] 2. Evaluation of the cleanliness of the cleaned stainless steel plate Figure 7 shows photographs of the stainless steel plate before and after cleaning. The left photograph in Figure 7 indicates that a sufficient amount of pseudo-contaminant was attached to the stainless steel plate before cleaning. As can be seen from the center photograph in Figure 7, red deposits were observed on the stainless steel plate when it was cleaned with water alone without any detergent. This indicates that EB-labeled BSA remained after cleaning. As can be seen from the right photograph in Figure 7, no deposits were observed on the stainless steel plate when it was cleaned with detergent. This indicates that no EB-labeled BSA remained after cleaning and was completely removed. Thus, it was demonstrated that the appropriateness of the cleaning procedure for an object can be evaluated by attaching EB-labeled BSA to the object as a pseudo-contaminant and cleaning it, and then visually checking whether the pseudo-contaminant remained on the object. [Explanation of symbols]

[0093] 10: Container containing suspected contaminated material 11: Packing box 12: Attached Documents

Claims

1. A step of attaching a pseudo-contaminant to an object; a step of cleaning the object to which the false contaminants are attached; Including, the pseudo-contaminant comprises a plurality of molecules of a labeled polypeptide; The labeled polypeptide is a polypeptide to which a dye is covalently attached, and the value of X calculated by the following formula is 100,000 or more: X = (number of dyes contained in one molecule of labeled polypeptide) x (molar extinction coefficient of the dye (M -1 cm -1 )) the pigment is erythrosine, The molar extinction coefficient of the dye is a value measured at 530 nm, The object is a medical device. How to clean the object.

2. 10. The method of claim 1, wherein the residual suspected contaminants on the cleaned object are an indicator of whether the cleaning operation was adequate.

3. A step of attaching a pseudo-contaminant to an object; a step of cleaning the object to which the false contaminants are attached; evaluating the suspected contaminants remaining on the cleaned object based on the dye; a step of determining whether the cleaning operation was appropriate based on the evaluation result; Including, the pseudo-contaminant comprises a plurality of molecules of a labeled polypeptide; The labeled polypeptide is a polypeptide to which a dye is covalently attached, and the value of X calculated by the following formula is 100,000 or more: X = (number of dyes contained in one molecule of labeled polypeptide) x (molar extinction coefficient of the dye (M -1 cm -1 )) the pigment is erythrosine, The molar extinction coefficient of the dye is a value measured at 530 nm, The object is a medical device. Methods for controlling the accuracy of cleaning operations.

4. A step of attaching a pseudo-contaminant to a first object; a step of cleaning a first object having the pseudo-contaminants attached thereto and a second object having biological contaminants attached thereto; evaluating the suspected contaminants remaining on the first object after cleaning based on the dye; determining whether the cleaning operation on the second object was appropriate based on the evaluation result; Including, the pseudo-contaminant comprises a plurality of molecules of a labeled polypeptide; The labeled polypeptide is a polypeptide to which a dye is covalently attached, and the value of X calculated by the following formula is 100,000 or more: X = (number of dyes contained in one molecule of labeled polypeptide) x (molar extinction coefficient of the dye (M -1 cm -1 )) the pigment is erythrosine, The molar extinction coefficient of the dye is a value measured at 530 nm, The object is a medical device. Methods for controlling the accuracy of cleaning operations.

5. In the attaching step, 1 cm of polypeptide concentration is 2 The method according to any one of claims 1 to 4, wherein the pseudo-contaminant is attached to the object at a rate of at least 2 µg per object.

6. 5. The method according to claim 4, wherein if the evaluation step evaluates that the remaining amount of the suspected contaminants on the first object is equal to or greater than a predetermined value, the determination step determines that the cleaning operation on the second object was inappropriate.

7. 5. The method according to claim 4, wherein if the evaluation step determines that the remaining amount of the suspected contaminant on the first object is less than a predetermined value or that no suspected contaminant remains, the determination step determines that the cleaning operation on the second object was appropriate.

8. The method according to claim 1, wherein the value of X is 350,000 or greater.

9. The method according to claim 1, wherein the value of X is 1,000,000 or more.

10. A method according to any one of claims 1 to 9, wherein the polypeptide is at least one protein or fragment thereof selected from the group consisting of albumin, casein and fibrin.

Images